Purchase Order 75N95019P00431
- Not listed
- <p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.</p>
- This federal contract award, identified as HHSN271201600029C, was made by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $271,070.00, was awarded to Regenhu SA, doing business as Regenhu LTD, a for-profit manufacturer of bioprinting equipment and platforms. The contract is for the delivery of a 3D bioprinter and associated equipment to support research...
- This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Pharmaron, Inc., a global contract research organization. The $281,751.22 purchase order contract is for a firm fixed price and does not have a set-aside designation. Under this contract, Pharmaron is conducting a variety of drug development activities to support the work of the NIH's National Center for Advancing Translational Sciences...
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...
- This contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to R & D Enterprises, Inc., a for-profit small business. The $104,180.00 firm fixed-price purchase order is for the provision of scientific instruments and accessories, such as mass spectrometers, thermal conductivity testers, and titration calorimeters, to support research and testing activities at NIDA's facilities in Bethesda,...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
This federal contract award was made by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to the prime contractor Arc Trinova LIMITED, a for-profit manufacturer based in Great Britain, United Kingdom. The $15,725.17 firm fixed-price purchase order contract is for regulatory support, research and development, and compatibility testing services to support the continued development of the drug 2R,6R-HNK. This award is not associated with a set-aside program. Arc Trinova LIMITED has received three prime federal contract awards from the Department of Health and Human Services since 2019, as well as one federal subcontract from Stanford University, to provide similar services. The National Institute on Drug Abuse is the funding agency for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($4k) | 8/7/24 | |
| Not listed | Not listed | $19.7k | 7/15/19 |